MedTrace Logo

Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment

NCT03362216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2017-12-08

No results posted yet for this study

Summary

This clinical trial program was established according to the ethical principles of the Helsinki declaration and the GCP guiding principle, and a randomized grouping method was used to evaluate the efficacy and safety of Compound Methyl Salicylate Liniment in the treatment of acute and chronic soft tissue pain with a positive control drug, named Diclofenac Sodium Liniment.

Conditions

  • Soft Tissue Injuries

Interventions

DRUG

Compound Methyl Salicylate Liniment

Compound Methyl Salicylate Liniment, apply to the affected area, 3 times a day.Course of treatment: 7 days

DRUG

Diclofenac Sodium Liniment

Diclofenac Sodium Liniment, apply to the affected area, 3 times a day. Course of treatment: 7 days

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • People's Hospital Peking University · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-07
Primary Completion
2009-05-22
Completion
2009-06-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03362216 on ClinicalTrials.gov